2022 TTS Thomas Starzl Innovation Award Recipient Revealed!

Professor Jan Lerut

Professor Jan Paul Marthe Lerut

Professor Jan Lerut has dedicated his professional life to transplant surgery, particularly liver and hepatobiliary surgery. In 2005, he founded the Starzl Transplant center in Brussels, Belgium. Under Professor Lerut’s leadership, the center has performed more than 2500 liver transplants (1,500 adults and 1,000 children) in addition to 4,000 kidney transplants.

Professor Lerut will deliver his acceptance speech during the President's Plenary session on Wednesday, September 14 during our TTS 2022 Congress being held in Buenos Aires from September 10-14, 2022.

Tom Starzl and Jan Lerut

About the Award

The TTS Starzl Innovation Award is named after Tom Starzl who was best known for his contributions to the field of organ transplantation, and often referred to as the “father of transplantation”. The award recognizes individuals who, though advanced and original work, have contributed significantly to transplantation, thereby reflecting the spirit pioneered by Dr. Starzl.
TTS Thomas Starzl Innovation Award is supported by

TTS Social Media Ambassadors

Interested in becoming a TTS Social Media Ambassador? Please contact Jennifer Groverman (jennifer.groverman@tts.org).

Welcome to our new Social Media Ambassadors!

On the occasion of the TTS 2022 Congress, our new SMA's will begin promoting the Congress as well as other TTS activities and initiatives. Included in the team are the two driving forces behind the success our Transplantation Journals' social media activities and innovations, Carla Baan (Executive Editor) and Macey Levan (Social Media Editor). They have both worked tirelessly in championing our journals, TTS and social media within our field. They will serve as our liaisons with their already very active journal social media team. We also welcome our current Councilor for North America, Dorry Segev, who is both a prolific tweeter and scientist. We are also very excited to further engage with Urmila Anadh, Stéphanie Lariviére, Hector Madariaga, Ana Cecilia Pastor Ludeña, and Leonie van Leeuwen) much better as they start promoting our activities.
Visit our TTS Social Media Ambassadors page to learn more about our Social Media Ambassadors.

See What’s On at TTS 2022!

You can now browse the detailed program and see who is presenting at TTS 2022. If you plan to attend virtually you can view the schedule in your local time zone.

Read the latest Congress newsletter

In this issue:
  • Are you planning to join us virtually?
  • Pre-Register online for in-person attendance by August 28
  • Special Sessions on September 11 Open to all registered delegates
  • Have you secured your spot for one of the pre-congress activities?
  • «Burden of Genius» Movie Screening
  • A special thank you to TTS 2022 Congress Sponsors

Register to the Congress (In-Person or Virtually)!

Hotel reservations are available here - Book early as space is limited!

In case you missed it from the last issue
CME for Utilizing a CDST for Resistant/Refractory CMV in SOT Patients

Watch the new video and earn CME!

Join Drs. Kotton, Razonable, and Humar as they illustrate how to use a new clinical decision support tool (CDST) for resistant or refractory cytomegalovirus (CMV) infection in solid organ transplant (SOT) patients. They will walk you through a challenging CMV resistant patient case and demonstrate how to enter clinical data into the novel CDST for optimal treatment decision making. An expert panel discussion provides opportunity for you to learn how to apply the CDST in practice and incorporate a new therapy, maribavir, into the care of SOT patients with resistant or refractory CMV infection.

In case you missed it from the last issue

Beatriz Dominguez-Gil, Spain
Director General
National Transplant Organization
TTS Past Councilor (Europe)

Dear colleagues and friends,

I am delighted to present you the 2020 Global report, the most comprehensive report that we have prepared so far, including data and information extracted from the Global Observatory on Donation and Transplantation (GODT).

On the one hand, this report presents the activity data on donation and transplantation at global, regional and country level, and also shows data related to the organ waiting lists, and donation and transplantation practices compared to the previous year, before the pandemic (2019).

I would like to highlight that the report addresses some pieces of information about legal aspects and organizational systems in place. This is the first time that this type of data are presented from 104 contributing Member States.


The Global Observatory on Donation and Transplantation (GODT) is the result of a collaborative effort between the World Health Organization (WHO) and the Spanish Organización Nacional de Trasplantes (ONT). The GODT was created in 2006 in response to World Health Assembly Resolution 57.18 requesting the Director General of the WHO to collect global data on the practices, safety, quality, efficacy, epidemiology and ethical issues of allogeneic transplantation. This request was further emphasized in Resolution 63.22 that also urged Member States to collaborate in the collection of such data. The GODT compiles global activity data on organ donation and transplantation, as well as country descriptions of legislations and regulatory oversights in place.
The Council of Europe Newsletter Transplant database and other international data collections, such as that performed by countries of the Iberoamerican Council/Network of Donation and Transplantation (RCIDT), are connected with the GODT to avoid duplication of efforts.
The aim of this report is to provide an overview of the current legislative and organizational situation of donation and transplantation in the world, as well as of organ donation and transplantation activities in the year 2020, a year marked by the COVID-19 pandemic.

TTC Public Workshop - September 22, 2022 @ 8AM ET

Since 2017 TTS has been participating in the Transplantation Therapeutics Consortium (TTC), a program of the Critical Path Institute.

Accelerating medical product development in kidney transplantation through a public-private partnership

This public workshop will be focusing on 1) qualifying a composite surrogate for long-term graft loss after kidney transplantation 2) real-world evidence (RWE) use in transplant clinical trials and 3) potential future endpoints in kidney transplantation The Transplant Therapeutics Consortium (TTC) aims to accelerate the medical product development process for transplantation by identifying challenges, prioritizing solutions, and developing tools to advance new product development to meet the most pressing needs of transplant recipients.
Click to view the agenda
Welcoming remarks
Session 1: Qualifying a composite surrogate for long-term graft loss after kidney transplantation
  • Regulatory qualification procedures and qualification status of the iBox Scoring System as a reasonably likely surrogate endpoint with FDA
  • Graphical user interface for sample size calculation using iBox scores
  • Panel discussion
Session 2: RWE use in transplant clinical trials
  • Regulatory and design considerations for RWE supplementation in transplant clinical trials
  • Pilot study for external control using the cyclosporine arm of the BENEFIT RCT versus UNOS/OPTN registry data
  • Sample size calculation and use RWE for supplemental external controls for the 5-year survival analyses
  • Panel discussion
Session 3: Future endpoints in kidney transplantation
  • Efficacy endpoints
  • Safety endpoints
  • Regulatory qualification procedures for clinical outcome assessments
  • Patient-reported outcome measures for transplantation
  • Panel discussion
Closing Remarks

TTS Needs Assessment Survey

This survey focuses on issues encountered by physicians in day-to-day decision-making.

Your responses will aid TTS in developing strategies, programs and resources to better improve access and transparency in transplantation, with an emphasis on increasing deceased donor organ transplantation.

The information collected will also aid the work TTS is doing as part of our World Health Organization collaboration.

All responses will be kept confidential and anonymous.

The survey will take 6+ minutes and must be done from a computer or tablet.

Meeting Announcement - September 16 - Brussels

The Joint Congress Belgian Transplantation Society (TTS Affiliated Society) & Belgian Society of Intensive Care Medicine will be held on September 16, 2022 in Brussels, Belgium. Please see details by clicking the button below.

Women in Transplantation & Asian Society of Transplantation - Fellowship Grant

Women in Transplantation is delighted to announce that they will co-sponsor a research fellowship grant with the Asian Society of Transplantation.
- Deadline is August 25, 2022-

The Asian Society of Transplantation will fund a research project that contributes to our understanding of the impact of sex and/or gender in transplantation using “Asian Society Transplant Registry-Women in transplantation-kidney transplantation (ASTREG-WIT-KT) data.”

ASTREG-WIT-KT is an online registry for data collection and analysis of gender disparity across Asia-Pacific countries. It was borne out of WIT's Pillar 2, which focuses on sex and gender research as it related to solid organ transplantation.

Any epidemiologic, clinical studies using this data will be considered for this grant.

In the News 



Staff Directory


The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6